ANVS ANNOVIS BIO
2026Q1 · CUSIP 03615A108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
55
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
19
Δ whales
-2
Inst. holding value
$10M
New positions
14
Closed positions
12
Price momentum (1Q)
—
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 1 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2021Q2 | Top 10% | -25.0% | -64.8% |
Options Sentiment
Put holders
3
QoQ: 0
Call holders
4
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.71
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)